Moderna, Inc. (MRNA) Stock Price History
Historical prices from 2018 to 2026
Loading 10-year price history...
MRNA Historical Performance
Short-Term Returns
MRNA Stock Price Trajectory (2018–2026)
As of May 6, 2026, Moderna, Inc. (MRNA) trades at $46.71, representing a +67.8% return over the past year. The stock has delivered a -71.3% total return over five years (-22.1% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $497.49 on August 10, 2021. From this peak, MRNA has corrected -90.6%, currently trading 30% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers BNTX (-5.5% 1Y), NVAX (+29.3% 1Y), and CVAC (+34.3% 1Y), MRNA has outperformed the peer group average. Compare MRNA vs BNTX →
MRNA Historical Price Data (2018–2026)
Showing 30 of 1,862 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-05 | 47.42 | 47.73 | 45.78 | 46.71 | 1.24M | -1.25% |
| 2026-05-04 | 45.32 | 47.97 | 45.32 | 47.30 | 7.58M | +4.25% |
| 2026-05-01 | 46.25 | 48.40 | 43.68 | 45.37 | 10.20M | -1.24% |
| 2026-04-30 | 46.21 | 47.94 | 45.75 | 45.94 | 6.04M | +0.48% |
| 2026-04-29 | 46.53 | 47.19 | 44.62 | 45.72 | 5.47M | -3.01% |
| 2026-04-28 | 48.79 | 48.93 | 46.75 | 47.14 | 3.64M | -3.20% |
| 2026-04-27 | 50.63 | 51.30 | 48.25 | 48.70 | 6.04M | -4.00% |
| 2026-04-24 | 53.38 | 53.49 | 50.57 | 50.73 | 4.30M | -4.01% |
| 2026-04-23 | 55.61 | 56.10 | 52.63 | 52.85 | 4.03M | -4.95% |
| 2026-04-22 | 55.40 | 55.93 | 54.35 | 55.60 | 3.48M | +2.53% |
| 2026-04-21 | 53.96 | 56.20 | 51.68 | 54.23 | 5.77M | -0.66% |
| 2026-04-20 | 53.60 | 55.73 | 53.02 | 54.59 | 5.55M | +1.62% |
| 2026-04-17 | 55.70 | 56.06 | 52.98 | 53.72 | 13.55M | -1.76% |
| 2026-04-16 | 54.13 | 54.95 | 52.76 | 54.68 | 4.99M | +0.77% |
| 2026-04-15 | 53.76 | 55.20 | 53.26 | 54.26 | 4.69M | +2.69% |
| 2026-04-14 | 50.91 | 53.00 | 50.05 | 52.84 | 5.26M | +4.26% |
| 2026-04-13 | 50.95 | 53.00 | 50.47 | 50.68 | 6.62M | -0.55% |
| 2026-04-10 | 51.67 | 52.89 | 50.02 | 50.96 | 6.27M | -0.62% |
| 2026-04-09 | 51.69 | 52.00 | 50.58 | 51.28 | 4.43M | -1.57% |
| 2026-04-08 | 51.99 | 52.39 | 50.54 | 52.10 | 4.81M | +3.97% |
| 2026-04-07 | 48.70 | 50.27 | 47.40 | 50.11 | 4.23M | +2.75% |
| 2026-04-06 | 49.07 | 49.80 | 48.20 | 48.77 | 3.48M | -0.87% |
| 2026-04-02 | 48.27 | 50.51 | 48.11 | 49.20 | 4.60M | -1.66% |
| 2026-04-01 | 51.89 | 52.78 | 49.58 | 50.03 | 7.38M | -1.52% |
| 2026-03-31 | 49.08 | 51.62 | 47.96 | 50.80 | 8.17M | +5.33% |
| 2026-03-30 | 49.83 | 49.85 | 47.14 | 48.23 | 5.21M | -2.68% |
| 2026-03-27 | 53.29 | 53.55 | 49.48 | 49.56 | 7.05M | -7.49% |
| 2026-03-26 | 52.67 | 54.64 | 52.30 | 53.57 | 3.81M | +0.06% |
| 2026-03-25 | 52.57 | 54.24 | 52.53 | 53.54 | 4.42M | +4.29% |
| 2026-03-24 | 50.44 | 52.68 | 50.34 | 51.34 | 4.80M | +0.12% |
Full MRNA Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See MRNA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MRNA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MRNA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMRNA — Frequently Asked Questions
Quick answers to the most common questions about buying MRNA stock.
How has MRNA stock performed recently?
MRNA returned +67.8% over the past year, beating its 5-year annualized CAGR of -22.1%. The stock trades above its 200-day moving average, confirming the uptrend.
What is MRNA's all-time high price?
Moderna, Inc. reached $497.49 on 2021-08-10. The 52-week high is $59.55. Current 1-year return of +67.8% places the stock closer to historical peaks.
Where can I download MRNA historical price data?
This page provides MRNA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2018-2026, downloadable in CSV format.